National Medicines Regulatory Authority (NMRA)
The National Medicines Regulatory Authority (NMRA) is an independent authority in the Ministry of Health established in 2015, ensuring that medicinal products meet safety, quality, and efficacy standards. It regulates medicines, medical devices, borderline products, clinical trials, and cosmetics.
The NMRA is governed by a board, which provides strategic leadership and advises on the authority’s functioning. The board does not have any involvement in regulatory decision-making, but the chief executive works with regulatory staff and expert advisory committees.
The primary objective is to increase patient access to quality-assured medicinal products. The NMRA has a code of conduct to ensure integrity, impartiality, and independence. Their work includes assessing medicinal product needs, registering, and licensing medicines, providing guidance on classification, regulating prices, regulating pharmacies, recommending amendments, educating the public, supporting post-marketing surveillance, and regulating clinical trials.
https://nmra.gov.lk/index.php?lang=en
THE NATIONAL MEDICINES REGULATORY AUTHORITY ACT, No. 5 OF 2015
Class I, IIa, IIb and III
The device registration and import into Sri Lanka is a three-step process:
The process demands the need to operate the device under sample license after which the manufacturer must again approach the NMRA for final approval, which again involves procuring multiple certifications.
The application for device approval along with a copy of sample Import License and samples for testing must be submitted to the NMRA. The agency also requires sample labels and Instructions for Use (IFU) in two locally recognized languages along with English and must be contextually aligned with original label which pose translation challenges.”
Electro medical equipment and machines: Submit the manufacturer’s or third-party laboratory’s batch release report.
Other products: Submit finished product test reports.
Independent analytical certificates for products in direct contact with the bloodstream (e.g., syringes, needles).
Analytical test reports from accredited laboratories for various products, following pharmacopeia standards where available.
Provide material test reports for items like sutures, medical instruments forceps, scissors).
Obtain ISO 13485 certification from an authorized notified body for design, development, manufacturing, and post-marketing monitoring.
Obtain CE accreditation from an authorized notified body, along with an EC design examination certificate if applicable.
Provide stability data for the entire shelf life of finished products if applicable.
Obtain approval from the Atomic Energy Authority of Sri Lanka for radiation emitting devices.
For animal-derived products like Surgical Catgut, obtain certification from the relevant health authority that the product is free from BSE.
Provide biological evaluation/biocompatibility test reports per ISO standards if applicable.
Include risk management analysis as per ISO standards if applicable.
Provide a recently issued validation report for the sterilization process for two commercial batches if applicable.
New full product registration will take a minimum of 6 months
New product registration-
Application for renewal should be made 6 months before the date of expiry of registration. A grace period will extend until the decision is given to the application for renewal.
Import licenses should be renewed every year.
If the requirements for registration are not satisfactory the application will be rejected completely.
Each new product will always be granted a 1-year provisional registration certificate. This certificate will be valid for 1 or 2 years. NMRA will mention if they require any additional information/documentation. After furnishing all additional requests to the authority, the full registration certificate with a longer expiration date will be granted.
Class | Definition | Time frame for recall |
I | The defect presents a life threatening or serious risk to health. | 24 hours – 10 days |
II | The defect may cause mistreatment or harm to the patient, but it is not life threatening or serious | Maximum up to 10 days |
III | The defect is unlikely to cause harm to the patient, and the recall is carried out for other reasons, such as non-compliance with the marketing authorization or regulations. | Maximum up to 30 days |
https://nmra.gov.lk/images/PDF/guideline/Guideline-on-Recall.pdf
Before placing a medical device into the market.
Contact us for free consultation: info@omcmedical.co.uk
Our team will be happy to respond your queries. Contact us directly with your questions or for scheduling FREE consultation and we’ll be in touch as soon as possible.
Our team will be happy to respond your queries. Contact us directly with your questions or for scheduling FREE consultation and we’ll be in touch as soon as possible.
Our team will be happy to respond your queries. Contact us directly with your questions or for scheduling FREE consultation and we’ll be in touch as soon as possible.
To launch a medical device in a country, medical devices must comply with the local country’s regulatory requirements. Let us be your trusted partner in bringing your medical devices to the Global market. Contact us today to learn more about how we can assist you in every step of the way.
This will close in 0 seconds